Immuno & Gene Therapy Committee


 The Immuno & Gene Therapy Committee strives to:

  • Assist in the planning of the annual meeting scientific program and the review of submitted abstracts in the dendritic cell and immunotherapy category.
  • Review the status of the immuno & gene therapy field and compile a list of major scientific issues that must be addressed to advance or enable cellular therapies utilizing immunotherapy and gene therapy.
  • Publish position papers and engage in scientific discourse as necessary to advance the field.

Projects and Objectives

  •  Contribute to the ISCT Annual Meeting program.

Committee Members:


Mitchell Cairo, MD
Chair (Jan 2016 - Dec 2017)
New York Medical College
New York, NY, United States



Lisa Butterfield, PhD
University of Pittsburgh
Pittsburgh, PA, United States
Bruce Levine, PhD
University of Pennsylvania
Philadelphia, PA, United States
Michaela Sharpe, PhD
Cell Therapy Catapult
London, United Kingdom
Derek Hart, MD
University of Sydney
Sydney, Australia
Patrick Hanley, PhD
Children's National Medical Center
Washington, DC, United States
Wei Dong Han, MD
Chinese PLA General Hospital
Beijing, China
David Gottlieb, MBBS, FRACP, FRCPA, MD
Westmead Hospital
Sydney, NSW, Australia
Donald Kohn, MD
University of California
Los Angeles, CA, United States
Mark Lowdell, PhD, FRCPath, FBS
University College London
London, United Kingdom
Sung-Yun Pai, MD
Boston Children's Hospital
Boston, MA, United States


© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.